Member Info for Nextlink

Closed up another 23 cents at $3.85
It does appear News is inbound.

I see looking further they are owned by
Meridian Bioscience, Inc. (VIVO) as sizable Nasdaq Company
Meridian Life Science, Inc. is a wholly owned subsidiary of Meridian Bioscience, Inc.

You may be onto something.
However Meridian Life Sciences are a small private Company based in Memphis
A leading large scale manufacturer of antibodies, viral antigens, recombinant proteins, and critical assay reagents.
Memphis, Tennessee, United States
11-50
Private
www.meridianlifescience.com/

Some many reasons people sell.
Here is one possible explanation in this particular case.
DC Thomson has revealed a £180m pre-tax loss which it is putting down to the initial impact of the coronavirus pandemic.
https://www.holdthefrontpage.co.uk/2021/news/publisher-pledges-titles-have-long-term-future-after-180m-loss/

More likely to be PDSB given all the activity over the last few trading days

Dwib you are deluded.
There are few if any shorters.
https://www.shorttracker.co.uk/companies/

Looks like the Hedge Funds have finished trading between themselves and
steadily wearing down Retail Investors, taking their shares off them for peanuts.
Turn around and closed above $3 up 48 cents on the day.
https://www.pdsbiotech.com/images/pdf/presentation/2021/Whitepaper-2021_v6.pdf
PDS Biotechnology management to meet virtually with Oppenheimer Virtual Meetings to be held February 1-2 hosted by Oppenheimer.

Maybe we will receive significant news sometime in February from PDS Biotechnology

434 million shares currently in issue.
Todays announcement states Mint may admit (sell) up to 6,000 million shares.
They may sell far fewer, however whichever way you look at it, there is massive dilution.
Thankful I am not currently holding many and hard for those who are.
Was expecting Eli news by now and it could come at any time.
As my money is tied up elsewhere I sit and watch how this develops.
On the plus side they will have £12 million and be progressing on many fronts.

Aberforth Partners LLP have gone from 5.78% to zero.
Maybe shorts closing has caused this price rise.
Thankful I do not and never have held.
Only for those with balls of steel I think.

Merck has dropped out of the CoVid vaccine race.

Merck and PDSB are using Versamune in combination with Keytruda (PDS0101)
Merck may also be aware of PDSBs CoVid vaccine candidate and the pre clinical data from Brazil.

Named Versamune-CoV-2FC, the vaccine has just received support from the National Health Surveillance Agency (Anvisa) to submit the documentation of the non-clinical trials for initial analysis, and subsequent submission of the protocol for the clinical trial.

Just out, Covid Vaccine finishing Animal Trials

https://g1.globo.com/sp/ribeirao-preto-franca/noticia/2021/01/21/startup-de-ribeirao-preto-quer-testar-vacina-contra-covid-19-em-maio-rotina-de-producao-esta-acelerada-diz-ceo.ghtml

I suspect large numbers of private investors are already gone and easy to see why.
Previous history reaching a peak of around £20 in mid 2015
( £2 before recent share consolidation) to recent lows of just over 40 pence.
I reckon fewer holders with larger holdings looking forward to significant gains.

They used to pay two Dividends a year.
It is a sign of their recovery that they have reinstated a Dividend.
I would anticipate a significant uplift in their next Dividend.

Song are almost £1.5 billion Market Cap.
So 100 times the vlaue of One Media and as you say no TCAT

Here we are almost 5 months since the Placing.
Low Market Cap, sp much lower than the Placing and in
the period some news on other holdings, but most on PDS Biotechnology.
Still some exiting at these low prices.
I can't help thinking we will soon receive news on at least one investment and
people will be scrambling to buy in.
With most weak holders gone and only 6 million shares in retail hands, possibly less
it indicates what is likely to happen.
The business model is similar to Braveheart, which I have been holding for several years.
In that time there were weeks when Braveheart was not traded, with a wide spread, I sat on
a loss most of the time.
Last year was entirely different and very profitable for me as a Braveheart investor.
I fully expect to repeat that with NSCI, as it appears the majority of private investors
find it difficult to deal with loss and holding in for any length of time in that situation.

https://www.pdsbiotech.com/images/pdf/presentation/2021/PDSB_Corporate_Overview_-_Jan_2021_FINAL.pdf

I do not believe Schroders sold any shares.
See RNS dated 5th August, which states admission of the Placing shares
was 25th August.
Schroders did not participate in the Placing and the resultant Dilution reduced
their percentage holding by the percentage notified today.

RUA

The drop was when they went ex dividend on 11th December.
Who knows what they will do on 6th January when the Dividend is paid.
It is possible some very happy Braveheart shareholders may add to their holdings
knowing news due at the end of January.